High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy-Reference-Cited by-同舟云学术

High-throughput genomic technology in research and clinical management of breast cancer. Plasma-based proteomics in early detection and therapy

Published:2006-12 Issue:6 Volume:8 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Davis Michael A,Hanash Samir

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr1619.pdf

Reference17 articles.

1. American Cancer Society: After the Tests: Staging. [ http://www.cancer.org/docroot/CRI/content/CRI_2_2_3X_After_the_tests_Staging_5.asp?sitearea= ]

2. Anderson NL, Anderson NG: The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002, 1: 845-867. 10.1074/mcp.R200007-MCP200.

3. Barry MJ: Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer. N Engl J Med. 2001, 344: 1373-1377. 10.1056/NEJM200105033441806.

4. Rustin GJ, Bast RC, Kelloff GJ, Barrett JC, Carter SK, Nisen PD, Sigman CC, Parkinson DR, Ruddon RW: Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer. Clin Cancer Res. 2004, 10: 3919-3926. 10.1158/1078-0432.CCR-03-0787.

5. Srivastava S, Srivastava RG: Proteomics in the forefront of cancer biomarker discovery. J Proteome Res. 2005, 4: 1098-1103. 10.1021/pr050016u.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of 14–3-3ζ as a potential biomarker in gastric cancer by proteomics-based analysis;Molecular Medicine Reports;2017-05

2. Latest Updates on Antiretinal Autoantibodies Associated With Vision Loss and Breast Cancer;Investigative Ophthalmology & Visual Science;2015-03-09

3. Breast Cancer Biomarkers for Risk Assessment, Screening, Detection, Diagnosis, and Prognosis;Omics Approaches in Breast Cancer;2014

4. Proteomic Approaches and Identification of Novel Therapeutic Targets for Alcoholism;Neuropsychopharmacology;2013-07-31

5. In vivo NIRF and MR dual-modality imaging using glycol chitosan nanoparticles;Journal of Controlled Release;2012-10